Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Proliferative Phase01:20

Proliferative Phase

670
The proliferative phase typically occurs after menstruation and lasts between 6 to 13 days in a standard 28-day cycle. This phase involves the reconstruction of the endometrium, guided by estrogen produced by the developing ovarian follicle.
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...
670
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

458
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
458
Ovarian Cycle01:27

Ovarian Cycle

1.6K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.6K
Histology of the Uterus01:19

Histology of the Uterus

1.7K
The uterine wall consists of three histological layers: the perimetrium, myometrium, and endometrium. The outermost perimetrium is a thin, serous membrane connected with the broad ligament on the sides, which helps anchor the uterus in the pelvic cavity. The thickest layer, myometrium, is mainly made up of smooth muscle tissue bundles. Its contractions are vital in facilitating the expulsion of the uterine lining, fetus, and placenta during menstruation and childbirth.
The endometrium is the...
1.7K
Oogenesis02:07

Oogenesis

64.0K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
64.0K
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

570
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
570

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Master Class: Writing a Case Report - Reflections on a Recently Published Case Report.

Gynecologic oncology reports·2026
Same author

Will they use it? Patient and provider acceptance of chatbot screening and counseling for hereditary cancer syndromes in a geographically underserved population.

Cancer prevention research (Philadelphia, Pa.)·2026
Same author

PRAME Expression in HPV-associated and Differentiated Vulvar Intraepithelial Neoplasia-associated Vulvar Squamous Neoplasia.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists·2026
Same author

HER2 and FOLR1 Expression in Mesonephric and Mesonephric-Like Adenocarcinomas in the Gynecologic Tract.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists·2026
Same author

Perioperative thrombin generation and fibrinolytic activation in patients undergoing major gynaecologic surgery for benign and malignant pathology: a pilot study.

BJA open·2026
Same author

MHC Class I and PD-L1 Expression May Predict Treatment Response to Anti-PD-1/PD-L1 Therapy in Metastatic Triple-negative Breast Cancer Patients.

Applied immunohistochemistry & molecular morphology : AIMM·2026
Same journal

The Political Determinants of Obstetric Prescribing.

Obstetrics and gynecology·2026
Same journal

Glucagon-Like Peptide-1 Receptor Agonists and Risk of Adverse Maternal Pregnancy Outcomes: A Systematic Review and Meta-analysis.

Obstetrics and gynecology·2026
Same journal

Milestones in Motion: Vaginal Birth After Cesarean.

Obstetrics and gynecology·2026
Same journal

Ebola Virus in Pregnancy.

Obstetrics and gynecology·2026
Same journal

A Quality-Improvement Study Evaluating Three Postpartum Prophylactic Oxytocin Rates and Blood Loss After Vaginal Birth.

Obstetrics and gynecology·2026
Same journal

The Effects of Climate Change on Obstetric and Gynecologic Health.

Obstetrics and gynecology·2026
See all related articles

Related Experiment Video

Updated: Aug 22, 2025

Generation of Multicellular Human Primary Endometrial Organoids
09:20

Generation of Multicellular Human Primary Endometrial Organoids

Published on: October 4, 2019

11.1K

Endometrial Hyperplasia.

Kari L Ring1, Anne M Mills, Susan C Modesitt

  • 1Gynecologic Oncology Division, Department of Obstetrics and Gynecology, and the Department of Pathology, University of Virginia Health System, Charlottesville, Virginia; and the Gynecologic Oncology Division, Gynecology and Obstetrics Department, Emory University, Atlanta, Georgia.

Obstetrics and Gynecology
|November 11, 2022
PubMed
Summary
This summary is machine-generated.

Endometrial hyperplasia, a precursor to cancer, requires prompt evaluation for abnormal bleeding. While hysterectomy is curative, fertility-sparing treatments and medical management are viable options for atypical hyperplasia (EIN).

More Related Videos

Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity
03:01

Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity

Published on: August 2, 2024

822
Two Methods for Establishing Primary Human Endometrial Stromal Cells from Hysterectomy Specimens
09:15

Two Methods for Establishing Primary Human Endometrial Stromal Cells from Hysterectomy Specimens

Published on: May 23, 2014

22.9K

Related Experiment Videos

Last Updated: Aug 22, 2025

Generation of Multicellular Human Primary Endometrial Organoids
09:20

Generation of Multicellular Human Primary Endometrial Organoids

Published on: October 4, 2019

11.1K
Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity
03:01

Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity

Published on: August 2, 2024

822
Two Methods for Establishing Primary Human Endometrial Stromal Cells from Hysterectomy Specimens
09:15

Two Methods for Establishing Primary Human Endometrial Stromal Cells from Hysterectomy Specimens

Published on: May 23, 2014

22.9K

Area of Science:

  • Gynecology
  • Oncology
  • Pathology

Background:

  • Abnormal uterine bleeding, particularly postmenopausal bleeding, is a key indicator of endometrial pathology, with 10-20% of cases being hyperplasia or cancer.
  • Atypical hyperplasia, or endometrial intraepithelial neoplasia (EIN), significantly increases the risk of concurrent or future endometrial cancer.

Purpose of the Study:

  • To provide a comprehensive review of endometrial hyperplasia, covering etiology, risk factors, classification, malignant potential, prevention, and treatment.
  • To outline current surgical and nonsurgical management strategies for endometrial hyperplasia and EIN.

Main Methods:

  • Literature review and synthesis of current clinical expert knowledge on endometrial hyperplasia.
  • Discussion of diagnostic criteria, risk stratification, and therapeutic options.

Main Results:

  • Key risk factors for EIN include genetic predispositions (e.g., Lynch syndrome), obesity, chronic anovulation, and polycystic ovarian syndrome.
  • Protective factors against EIN include oral contraceptive use and progesterone-containing intrauterine devices.
  • Hysterectomy is the definitive treatment for EIN, but nonsurgical options are increasingly considered due to patient factors like obesity, fertility desires, and comorbidities.

Conclusions:

  • Prompt evaluation of abnormal uterine bleeding is crucial for diagnosing endometrial hyperplasia and cancer.
  • EIN necessitates treatment due to its high risk of malignant progression.
  • Treatment decisions for EIN should be individualized, considering hysterectomy alongside fertility-sparing and medical management options.